UCSF

2005 News

While a number of antiviral medications are used to combat typical types of influenza, only 2 are active against the new avian influenza virus, known as H5N1, according to Joseph Guglielmo, PharmD, UCSF School of Pharmacy professor and clinical pharmacist specializing in medications to treat infectious diseases.
For the 2nd consecutive year, UCSF topped all United States universities and colleges in both total and federally financed spending for chemistry research and development. These results reflect data for 2003 from the National Science Foundation. These are the most recent statistics available as of August 2005.
UCSF is the recipient of a US$1 million, 3-year grant from the Howard Hughes Medical Institute (HHMI) to create a new and radical PhD program to train systems biologists. Graduates will be able to apply mathematics, physics, and engineering to biological questions, and effectively communicate their own ideas while welcoming the different ideas of others.
By genetically engineering microbes to act like biological camera film, UCSF School of Pharmacy assistant professor Christopher A. Voigt, PhD and doctoral students show the potential of the new field of synthetic biology to create useful tools for medicine and technology. Details of this research appeared November 24, 2005 in Nature. • Full story: Scientists engineer bacteria to create living photographs.
Leaders from 6 Vietnamese pharmacy schools joined with the University of California, San Francisco (UCSF) School of Pharmacy and UCSF Global Health Sciences, and the United States Pharmacopeia to sign a partnership agreement on November 12, 2005 in Ho Chi Minh City, Vietnam to expand the role of pharmacists and pharmacies in Vietnam.
A research collaboration between the University of California (UC) and Peking University will integrate the biological data acquisition strengths of the former with the physical and theoretical strengths of the latter, a move which scientists anticipate will ultimately lead to more effective, safer medications for populations and individuals.
Robert Langridge, PhD, professor emeritus of the School of Pharmacy, University of California, San Francisco, is highlighted as one of 35 innovators of our time by the editors of Smithsonian Magazine in its November 5, 2005 issue.
A unique course of study offered by UCSF's School of Pharmacy has led a strong student to realize his goal of doing research and helping patients overseas. It has helped him to win a prized Fulbright Fellowship to boot.
Dissolving thin strips containing over-the-counter medicines are now being used by consumers to treat their coughs and colds and runny noses.
A new benefit for prescription drugs will be offered through Medicare beginning January 1, 2006. Medicare recipients who are eligible for this benefit must evaluate their drug benefit options and enroll in a drug plan.
Attempts have failed by Health Management Organizations (HMOs) to cut drug costs by putting physicians at financial risk if their prescription costs exceed their medical group's drug budget. This was the finding of a study led by School of Pharmacy faculty member Helene Levens Lipton, PhD, which was released September 5, 2005 in Journal of Health Policy Politics and Law. • More information: Key Strategy to Limit Managed Care Drug Costs Failing, Survey Shows.
Lisa Bero, PhD
The same level of legal scrutiny that applies to research funded by the US government should apply to research funded by industry, according to UCSF School of Pharmacy faculty member Lisa Bero, PhD, and co-authors of a study that appeared July 20, 2005 in the online issue of American Journal of Public Health.
Kathy M. Giacomini, PhD, UCSF School of Pharmacy scientist, received the 2005 Paul Dawson Biotechnology Award in Cincinnati, Ohio on July 10, 2005 from the American Association of Colleges of Pharmacy (AACP). The award recognizes exceptional teaching and research in biotechnology.
Katherine Yang, PharmD, MPH, UCSF School of Pharmacy assistant clinical professor, is one of nine UCSF faculty members awarded a grant from the National Institutes of Health (NIH) to support early career development of researchers.
James Wells
James Wells, PhD, a leader in the development of new technologies to aid drug discovery and protein engineering, joins UCSF as the first holder of the Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences. Wells will hold joint faculty appointments in the Schools of Pharmacy and Medicine. Wells is a member of the National Academy of Sciences and co-founder of Sunesis, the South San Francisco pharmaceutical company.
The UCSF School of Pharmacy was the largest recipient of 2004 research funding from the National Institutes of Health (NIH) among pharmacy schools in the United States. The School's 2004 total NIH award funding was US$23.5 million. "The 2004 ranking marks the 25th consecutive year we've received top NIH funding," said Mary Anne Koda-Kimble, PharmD, dean, UCSF School of Pharmacy. The 1979 figure was US$1.7 million. This is quite an accomplishment."
The growing use of herbals and dietary supplements calls for increasing consumer education of products, their ingredients and effects, possible interactions with other medications, and much more. Candy Tsourounis, PharmD, director of the Drug Information Analysis Service, School of Pharmacy, University of California, San Francisco, shares practical tips on how to use herbals and dietary supplements effectively and safely in an interview on KQED radio, April 21, 2005.
medications
The ethical issues behind a pharmacist's personal decision to dispense or not dispense emergency contraceptives and other drugs is explored by doctor of pharmacy students at the School of Pharmacy, University of California, San Francisco, in a required course on pharmacy law and ethics.
The pros and cons of legislating a pharmacist's right to refuse to dispense emergency contraceptive medications was the topic of discussion at a meeting held Tuesday, April 19, 2005 among doctor of pharmacy students from the School of Pharmacy, University of California, San Francisco and law students from the University of San Francisco. Full story: Conscience Clauses Stir Debate Among Scholars More information:
More than 20 high school students from California's central valley city of Fresno spent a day in early February 2005 with local pharmacists in various practice settings to get a close look at pharmacy as a career option.
Whether or not pharmacists or pharmacies should be legally allowed to refuse to dispense medications is the cause of current state and national discussion and proposed legislation. At center stage are contraceptives. Speaking out are right to life and pro choice advocates as well as pharmacists, pharmacy owners, legislators, and attorneys on both sides of the issue.
Tanja Kortemme
UCSF School of Pharmacy scientist Tanja Kortemme, PhD, is a 2005 recipient of the prestigious Sloan Research Fellowship awarded by the Alfred P. Sloan Foundation.
The UCSF School of Pharmacy maintains its ranking as the best doctor of pharmacy degree program in the United States, according to a survey conducted by U.S. News & World Report. Results were published in the magazine's April 11, 2005 issue and in its special report, "America's Best Graduate Schools 2006 Edition." • Full story: [UCSF Schools of Pharmacy, Medicine Rank Among Nation's Best in Annual Survey, America's Best Graduate Schools 2006 Edition] [link defunct].
Mary Anne Koda-Kimble, PharmD, dean of the School of Pharmacy, University of California, San Francisco has been reelected to the United States Pharmacopeia (USP) Board of Trustees. Her second term begins March 2005 and ends March 2010.
Steve Kayser, PharmD, clinical pharmacist and cardiology drug expert warns that the risks could outweigh the benefits of making cholesterol-lowering drugs, called statins, available in the United States without a prescription. In January 2005, two United States Food and Drug Administration expert committees voted down such a proposal for American consumers, citing concerns for patient safety. Statins are now available over the counter in the United Kingdom.
Chris Voigt
UCSF School of Pharmacy scientist Christopher A. Voigt, PhD is a 2005 recipient of the prestigious Sloan Research Fellowship awarded by the Alfred P. Sloan Foundation.
The Center for Drug Development Science (CDDS), located in Washington, DC, has joined with the UCSF School of Pharmacy to advance the safe and effective use of drugs. CDDS moved its academic affiliation in fall 2004 from Georgetown University to UCSF, while retaining its District of Columbia location at the University of California Washington, DC Center building, just six blocks from the White House.
Koda-Kimble
Special Report / Fall-Winter 2005: An overview of School accomplishments based upon a written report that Dean Mary Anne Koda-Kimble, PharmD submitted to a UCSF faculty committee as part of a review of her performance as dean from 1998 to 2003. Includes updates from 2003 through March 2005. "My first 5 years as dean…and since" and more.
Kathy M. Giacomini, PhD, chair of the UCSF School of Pharmacy Department of Biopharmaceutical Sciences is one of five new members appointed to the National Advisory General Medical Sciences Council. The appointment came from Tommy Thompson, US Secretary of the Department of Health and Human Services. The council serves the National Institute of General Medical Sciences (NIGMS), which is one of the US National Institutes of Health.
More than 33% of adults in the US pursue non-conventional medical treatments, therapies, and techniques. These include acupuncture, herbal remedies, and homeopathy, respectively. In light of this fact, the Institute of Medicine (IOM) convened an expert committee to study the extent of complementary and alternative medicine (CAM) use by Americans. In a report released January 12, 2005, the committee recommends: